retatrutide triple agonist clinical trial is gaining attention in metabolic research for its activity on GIP, GLP-1, and glucagon receptors. In this carousel, we summarize recent study findings related to weight management, type retatrutide #obesity #osteoarthritis #clinicaltrials #medicine

Similar to the other GLP-1s, there is a version approved for weight loss (Saxenda) and one for treatment of type 2 diabetes (Victoza)

Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents

(2024) 15:e0203223

I am already seeing results, and I am so glad I found Next Medical for all of these reasons

Bonus step: Combine Temu reviews with Google and Facebook reviews Besides embedding a Temu review or two, EmbedSocial offers: Tools to collect reviews from platforms like Google, Facebook, and Yelp, Photo reviews to make your testimonials visually appealing, Analytics to track the performance of your review widget and optimize its placement

Lemas, PhD, assistant professor in the department of health outcomes and biomedical informatics, and faculty member at the Institute for Child Health Policy at University of Florida College of Medicine, said the FDA currently recommends that women stop using GLP-1s at least 2 months before conception due to fetal toxicity that was observed in some animal studies